The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
GRADE guidelines: 9.Rating up the quality of evidence
Pages: 1459-1463
Year: Issue:  12
Journal: Chinese Journal of Evidence-Based Medicine

Keyword:  GRADE指南证据等级观察性研究效应量大偏倚风险;
Abstract: 证据质量升级的最常见原因是效应量大.当方法学严谨的观察性研究表明风险至少降低或增加2倍时,GRADE建议考虑将证据质量升高1级;当风险至少降低或增加5倍时,考虑将证据质量升高2级.当存在剂量-反应关系,或所有合理的混杂、偏倚会降低明显的治疗效应,或混杂、偏倚使得结果无效为假效应时,系统评价作者和指南制定者也可考虑升高证据质量.其他考虑因素包括起效迅速、潜在的疾病(状态)趋势以及间接证据.
Related Articles
No related articles found